Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Covariate-adjusted response-adaptive designs for binary response.

W F Rosenberger1, A N Vidyashankar, D K Agarwal

  • 1Department of Mathematics and Statistics, University of Maryland, Baltimore County, Balitmore 21250, USA.

Journal of Biopharmaceutical Statistics
|May 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical innovation revisited: A historical narrative of the minimally invasive "Agarwal sliding-clip renorrhaphy" technique for partial nephrectomy and its application to an Australian cohort.

BJUI compass·2022
Same author

A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.

Methods of information in medicine·2015
Same author

Expanding the living renal donor pool by using a horseshoe kidney.

Indian journal of nephrology·2015
Same author

Assessment of Corticotomy Facilitated Tooth Movement and Changes in Alveolar Bone Thickness - A CT Scan Study.

Journal of clinical and diagnostic research : JCDR·2014
Same author

Antiparasitic efficacy of a novel plant-based functional food using an Ascaris suum model in pigs.

Acta tropica·2014
Same author

Development of Strongylus vulgaris-specific serum antibodies in naturally infected foals.

Veterinary parasitology·2014
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This study introduces an adaptive allocation design for clinical trials using covariates. The method offers modest savings in treatment failures while maintaining similar power to traditional methods, making it attractive for specific studies.

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Pharmaceutical Research

Background:

  • Adaptive designs enhance clinical trial efficiency.
  • Covariate incorporation can improve treatment allocation.
  • Traditional methods may not fully leverage patient-specific data.

Purpose of the Study:

  • To describe an adaptive allocation design for phase III clinical trials incorporating covariates.
  • To evaluate the performance of this adaptive design through simulations.
  • To assess the potential benefits in terms of treatment failures and statistical power.

Main Methods:

  • Developed an adaptive allocation scheme using logistic regression to map covariate-adjusted odds ratios.
  • Simulated clinical trial scenarios with staggered entry and time to response.

Related Experiment Videos

  • Assessed performance under various probability distributions dependent on treatment, response, covariates, and time trends.

    • Main Results:

    • Confidence intervals for the covariate-adjusted odds ratio were slightly anticonservative under the null hypothesis.
    • Statistical power was comparable to equal allocation for sample size n=200 under various alternatives.
    • Modest net savings in expected treatment failures were observed for similar power levels.

    Conclusions:

    • The adaptive covariate-incorporating design is attractive for phase III trials where covariates are important and stratification is not desired.
    • This design offers potential ethical and resource benefits by reducing treatment failures.
    • It provides a viable alternative to traditional allocation methods when managing patient heterogeneity is crucial.